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646 Combined autologous cellular cardiomyoplasty with skeletal myoblasts and
bone marrow cells in canine hearts for ischemic cardiomyopathy
Imran A. Memon, MBBS, Yoshiki Sawa, MD, Shigeru Miyagawa, MD, Satoshi Taketani, MD,
and Hikaru Matsuda, MD, Osaka, Japan
By use of autologous myoblasts and bone marrow mononuclear cell transplantation, myogenesis
and angiogenesis were achieved in infarcted myocardium, suggesting a therapy for
improvement in cardiac performance.
654 Hemodilution and surgical hemostasis contribute significantly to transfusion
requirements in patients undergoing coronary artery bypass
Sandra Dial, MD, MSc, Eugene Delabays, MD, Martin Albert, MD, Anne Gonzalez, MD,
Jordan Camarda, BSc, Adora Law, BSc, and Dick Menzies, MD, MSc, Montreal, Quebec, Canada
We sought to determine the risk factors for the development of low intraoperative hematocrit
levels and of excessive postoperative bleeding in patients undergoing CABG, whether the risk
factors are the same, and their effect on blood product transfusions.
662 Aprotinin improves kidney function and decreases tubular cell apoptosis and
proapoptotic signaling after renal ischemia-reperfusion
Ajay Kher, MD, Kirstan K. Meldrum, MD, Karen L. Hile, BS, Meijing Wang, MD,
Ben M. Tsai, MD, Mark W. Turrentine, MD, John W. Brown, MD, and
Daniel R. Meldrum, MD, Indianapolis, Ind
The effects of aprotinin were studied in a rat model of renal ischemia-reperfusion. Aprotinin
provided protection from renal ischemia-reperfusion injury and may do so by affecting
apoptotic signaling and inflammatory cytokine production.
670 Pharmacologic cerebral capillary blood flow improvement after deep hypothermic
circulatory arrest: An intravital fluorescence microscopy study in pigs
Lotfi Ben Mime, MD, Stefan Arnhold, MD, Juergen Hartmut Fischer, MD, Klaus Addicks, MD,
Ernst Rainer de Vivie, MD, Gerardus Bennink, MD, and Michael Suedkamp, MD,
Cologne, Germany
The platelet glycoprotein IIb/IIIa inhibitor eptifibatide can safely be used in the setting of
DHCA–reperfusion when performing cardiac surgery. It improves prevailing cerebral capillary
blood flow and reduces cerebral edema significantly.
677 Mechanical deterioration underlies malignant behavior of aneurysmal
human ascending aorta
George Koullias, MD, Raj Modak, MD, Maryann Tranquilli, RN, Dimitris P. Korkolis, MD,
Paul Barash, MD, and John A. Elefteriades, MD, New Haven, Conn
Mechanical properties of the aneurysmal ascending aorta were measured in patients before aortic
replacement and compared with those of nondilated aortas. Mechanical properties were found to
deteriorate dramatically as the aorta approached 6 cm diameter. This mechanical deterioration
probably underlies the malignant clinical behavior of the aorta at these dimensions.
684 A femoral artery cannula that allows distal blood flow
James A. Magovern, MD, James D. Fonger, MD, David H. J. Wang, PhD, Dennis Kopilec, PhD,
Dennis R. Trumble, MS, and Douglas E. Smith, PhD, Pittsburgh, Pa, and New York, NY
A distal-flow cannula was developed and tested in a porcine model. Ultrasonic flow probe and
microsphere data demonstrated more distal flow and perfusion with this cannula than with a
standard cannula of the same size.
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